[ad_1]
Well being know-how firm PicnicHealth introduced it’s transferring into the oncology area and teaming up with AstraZeneca to construct a registry to generate real-world knowledge on breast most cancers.
The corporate says it should work with folks dwelling with most cancers to gather and construction their medical data knowledge to advance oncology analysis utilizing strong datasets.
Moreover, the California-based firm introduced a multiyear partnership with biopharmaceutical large AstraZeneca to create a registry to generate longitudinal real-world knowledge from consenting U.S. sufferers recognized with stage 1 to stage 3 breast most cancers.
The registry, which sufferers can at the moment enroll in, will set up their medical data right into a centralized portal and permit sufferers to contribute their de-identified knowledge to breast most cancers analysis.
“We’re best-suited for companions that wish to leverage our expertise working immediately with sufferers to develop richer, extra full datasets that supply a window into the affected person expertise for sufferers with early most cancers diagnoses. Since these sufferers are sometimes prone to survive their cancers or dwell with most cancers for an prolonged time frame, working with these sufferers to develop datasets performs to our power in affected person engagement and our capability to synthesize affected person data throughout care websites together with patient-reported outcomes,” Dr. Dan Drozd, chief medical officer at PicnicHealth, instructed MobiHealthNews in an e-mail.
THE LARGER TREND
In April, PicnicHealth introduced a partnership with pharma large Roche and its subsidiary Genentech to speed up neurological illness analysis via investments in real-world knowledge. Roche deliberate to leverage PicnicHealth’s datasets for Alzheimer’s Illness, Alzheimer’s Illness-related dementias and myasthenia gravis, a persistent autoimmune dysfunction leading to weak point of the skeletal muscle tissues.
The identical month, it announced it would partner with international nonprofit firm CureDuchenne, which focuses on discovering a remedy for Duchenne muscular dystrophy. The pair would bolster real-world proof technology for the CureDuchenne Hyperlink platform.
Final yr, PicnicHealth scored $60 million in Series C funding, two years after it secured $35 million in equity financing.
The information firm additionally announced a partnership with international biopharmaceutical firm Bristol Myers Squibb to merge datasets to higher perceive sufferers with obstructive hypertrophic cardiomyopathy.
In 2021, PicnicHealth and Komodo Health shaped a partnership to collectively use their merchandise to create a real-world affected person knowledge pool utilizing de-identified knowledge from payers, suppliers, labs and digital well being data, after which present that knowledge to biopharmaceutical and educational communities.
[ad_2]
